These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1241109)

  • 21. [Cerebral vasospasm. Re-evaluation of the factors which have been claimed to be the cause of vasospasm (author's transl)].
    Osaka K
    Nihon Geka Hokan; 1977 Jul; 46(4):380-95. PubMed ID: 921465
    [No Abstract]   [Full Text] [Related]  

  • 22. [Supratentorial craniotomy of the cisternal clot removal in cases with ruptured aneurysms in the posterior fossa].
    Niwa J; Kubota T; Okuyama T; Shimizu K; Hirai H
    No Shinkei Geka; 1990 Apr; 18(4):385-9. PubMed ID: 2374651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Norepinephrine (NE) in cerebral vasospasm: assay of NE in CSF from patients with a ruptured intracranial aneurysm and its role in experimental vasospasm (author's transl)].
    Shigeno T
    No To Shinkei; 1981 Jun; 33(3):537-45. PubMed ID: 7259893
    [No Abstract]   [Full Text] [Related]  

  • 24. Cisternal talc injection in dog can induce delayed and prolonged arterial constriction resembling cerebral vasospasm morphologically and pharmacologically.
    Nagata K; Sasaki T; Mori T; Nikaido H; Kobayashi E; Kim P; Kirino T
    Surg Neurol; 1996 May; 45(5):442-7. PubMed ID: 8629244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chlorpromazine on experimental delayed cerebral vasospasm.
    Nakano M; Tani E; Fukumori T; Yokota M
    J Neurosurg; 1984 Nov; 61(5):857-63. PubMed ID: 6491731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The study of occurrence mechanism in acute and chronic cerebral vasospasm].
    Jiang K
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):344-6, 383. PubMed ID: 1304997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebral vasospasm: comparison of contractile responses in isolated human and canine basilar arteries].
    Tanishima T
    No To Shinkei; 1983 Apr; 35(4):323-9. PubMed ID: 6575794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of arterial and venous wall homogenates, arterial and venous blood, and different combinations to the cerebral vasospasm in an experimental model.
    Cansever T; Canbolat A; Kiriş T; Sencer A; Civelek E; Karasu A
    Surg Neurol; 2009 May; 71(5):573-9; discussion 579. PubMed ID: 18514267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the dopamine induced hypertension therapy for vasospasm (author's transl)].
    Haraguchi S; Ebina K
    No Shinkei Geka; 1982 Mar; 10(3):279-89. PubMed ID: 7099370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral arterial spasm. 3. In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine.
    Allen GS; Gold LH; Chou SN; French LA
    J Neurosurg; 1974 Apr; 40(4):451-8. PubMed ID: 4814376
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental evaluation of the spasmogenicity of dopamine on the basilar artery.
    White RP; Hagen A; Robertson JT
    J Neurosurg; 1976 Jan; 44(1):45-9. PubMed ID: 472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The surgical treatment of cerebral ischaemia due to vertebral artery and subclavian artery insufficiency (author's transl)].
    Carstensen G
    Rontgenblatter; 1978 May; 31(5):272-5. PubMed ID: 653247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm.
    Yokota M; Tani E; Maeda Y; Kokubu K
    Stroke; 1987; 18(2):512-8. PubMed ID: 3564111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental assessment of phenoxybenzamine in cerebral vasospasm.
    White RP; Huang SP; Hagen AA; Robertson JT
    J Neurosurg; 1979 Feb; 50(2):158-63. PubMed ID: 430126
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebral arterial spasm. II. Etiology and treatment of experimental cerebral vasospasm.
    Morooka H
    Acta Med Okayama; 1978 Apr; 32(1):39-49. PubMed ID: 207156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental catecholamine-induced chronic cerebral vasospasm. Myonecrosis in vessel wall.
    Alksne JF; Greenhoot JH
    J Neurosurg; 1974 Oct; 41(4):440-5. PubMed ID: 4213103
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm.
    Egemen N; Türker RK; Sanlidilek U; Zorlutuna A; Bilgiç S; Baskaya M; Unlü A; Caglar S; Spetzler RF; McCormick JM
    Neurol Res; 1993 Oct; 15(5):310-5. PubMed ID: 7905604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cerebral vascular effects of a new derivative of 1,4-dihydropyridine (YC-93), with special reference to its effect on the experimental basilar artery spasm in cats (author's transl)].
    Handa J
    Nihon Geka Hokan; 1975 Jul; 44(4):343-51. PubMed ID: 1238067
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oxyhemoglobin-induced cerebral vasospasm and sequential changes of vascular ultrastructure (author's transl)].
    Okada H; Endo S; Kamiyama K; Suzuki J
    Neurol Med Chir (Tokyo); 1980 Jun; 20(6):573-82. PubMed ID: 6158005
    [No Abstract]   [Full Text] [Related]  

  • 40. Sequential morphological changes of the constrictive basilar artery in a canine model of experimental cerebral vasospasm by talc injection.
    Mori T; Nagata K; Ishida T; Nikaido H; Kobayashi E; Sasaki T; Ohami H; Kirino T
    J Vet Med Sci; 1994 Jun; 56(3):535-40. PubMed ID: 7948385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.